149 related articles for article (PubMed ID: 18022979)
1. A small molecular scaffold for selective inhibition of Wip1 phosphatase.
Bang J; Yamaguchi H; Durell SR; Appella E; Appella DH
ChemMedChem; 2008 Feb; 3(2):230-2. PubMed ID: 18022979
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
3. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
[TBL] [Abstract][Full Text] [Related]
4. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
Xia Y; Ongusaha P; Lee SW; Liou YC
J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
[TBL] [Abstract][Full Text] [Related]
5. Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.
Yamaguchi H; Durell SR; Feng H; Bai Y; Anderson CW; Appella E
Biochemistry; 2006 Nov; 45(44):13193-202. PubMed ID: 17073441
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificity of the human protein phosphatase 2Cdelta, Wip1.
Yamaguchi H; Minopoli G; Demidov ON; Chatterjee DK; Anderson CW; Durell SR; Appella E
Biochemistry; 2005 Apr; 44(14):5285-94. PubMed ID: 15807522
[TBL] [Abstract][Full Text] [Related]
7. Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction.
Gilmartin AG; Faitg TH; Richter M; Groy A; Seefeld MA; Darcy MG; Peng X; Federowicz K; Yang J; Zhang SY; Minthorn E; Jaworski JP; Schaber M; Martens S; McNulty DE; Sinnamon RH; Zhang H; Kirkpatrick RB; Nevins N; Cui G; Pietrak B; Diaz E; Jones A; Brandt M; Schwartz B; Heerding DA; Kumar R
Nat Chem Biol; 2014 Mar; 10(3):181-7. PubMed ID: 24390428
[TBL] [Abstract][Full Text] [Related]
8. Sanguinarine as a potent and specific inhibitor of protein phosphatase 2C in vitro and induces apoptosis via phosphorylation of p38 in HL60 cells.
Aburai N; Yoshida M; Ohnishi M; Kimura K
Biosci Biotechnol Biochem; 2010; 74(3):548-52. PubMed ID: 20208361
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
10. LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1).
An H; Lu X; Liu D; Yarbrough WG
PLoS One; 2011 Jan; 6(1):e16427. PubMed ID: 21283629
[TBL] [Abstract][Full Text] [Related]
11. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation.
Song JY; Han HS; Sabapathy K; Lee BM; Yu E; Choi J
J Biol Chem; 2010 Mar; 285(12):9067-76. PubMed ID: 20093361
[TBL] [Abstract][Full Text] [Related]
12. Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.
Schito ML; Demidov ON; Saito S; Ashwell JD; Appella E
J Immunol; 2006 Apr; 176(8):4818-25. PubMed ID: 16585576
[TBL] [Abstract][Full Text] [Related]
13. PP2Cdelta (Ppm1d, WIP1), an endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development.
Hickson JA; Fong B; Watson PH; Watson AJ
Mol Reprod Dev; 2007 Jul; 74(7):821-34. PubMed ID: 17219434
[TBL] [Abstract][Full Text] [Related]
14. Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis.
Belova GI; Demidov ON; Fornace AJ; Bulavin DV
Cancer Biol Ther; 2005 Oct; 4(10):1154-8. PubMed ID: 16258255
[TBL] [Abstract][Full Text] [Related]
15. Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase.
Robello M; Zheng H; Saha M; George Rosenker KM; Debnath S; Kumar JP; Tagad HD; Mazur SJ; Appella E; Appella DH
Eur J Med Chem; 2022 Dec; 243():114763. PubMed ID: 36179402
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D.
Chuman Y; Yagi H; Fukuda T; Nomura T; Matsukizono M; Shimohigashi Y; Sakaguchi K
Protein Pept Lett; 2008; 15(9):938-48. PubMed ID: 18991770
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.
Bulavin DV; Phillips C; Nannenga B; Timofeev O; Donehower LA; Anderson CW; Appella E; Fornace AJ
Nat Genet; 2004 Apr; 36(4):343-50. PubMed ID: 14991053
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK.
Wang HY; Liu ZS; Qiu L; Guo J; Li YF; Zhang J; Wang TJ; Liu XD
Oncol Res; 2014; 22(4):225-233. PubMed ID: 26351212
[TBL] [Abstract][Full Text] [Related]
19. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
[TBL] [Abstract][Full Text] [Related]
20. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.
Takekawa M; Adachi M; Nakahata A; Nakayama I; Itoh F; Tsukuda H; Taya Y; Imai K
EMBO J; 2000 Dec; 19(23):6517-26. PubMed ID: 11101524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
